Novel glutamatergic drugs for the treatment of mood disorders
Kyle AB Lapidus, Laili Soleimani, James W MurroughMood and Anxiety Disorders Program, Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USAAbstract: Mood disorders are common and debilitating, resulting in a significant public health burden. Current treatments are only...
Enregistré dans:
| Auteurs principaux: | , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Dove Medical Press
2013
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/c642c0191b914f869c9fb57dce8d4303 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|